Maria Gonzalez-Perez

Carlos III Institute of Health - National Centre for Microbiology

Monforte de Lemos 5

Madrid, Madrid 28029

Spain

SCHOLARLY PAPERS

3

DOWNLOADS
Rank 8,713

SSRN RANKINGS

Top 8,713

in Total Papers Downloads

7,806

SSRN CITATIONS

1

CROSSREF CITATIONS

0

Scholarly Papers (3)

1.

Reactogenicity and Immunogenicity of BNT162b2 in Subjects Having Received a First Dose of ChAdOx1s: Initial Results of a Randomised, Adaptive, Phase 2 Trial (CombiVacS)

Number of pages: 38 Posted: 27 May 2021
La Paz University Hospital - Servicio de Farmacología Clínica, La Paz University Hospital - Servicio de Farmacología Clínica, Carlos III Institute of Health - Laboratorio de Serología, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), Hospital Vall d’Hebron - Servicio de Medicina Preventiva y Epidemiología, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Carlos III Institute of Health - National Centre for Microbiology, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Carlos III Institute of Health - Laboratorio de Serología, Institut de Recerca Hospital Universitari Vall d’Hebron (VHIR) - Unidad de Soporte a la Investigación Clínica, Universidad Complutense de Madrid (UCM) - Servicio de Farmacología Clínica, University Hospital 12 de Octubre, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Autonomous University of Barcelona - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Universidad Autónoma de Madrid - Hospital Universitario La Paz. IdiPAZ, Carlos III Institute of Health - Laboratorio de Referencia en Inmunología, Carlos III Institute of Health - AIDS Immunopathogenesis Unit, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica and Independent
Downloads 7,722 (1,201)
Citation 11

Abstract:

Loading...

Immunogenic Dynamics and SARS-CoV-2 Variants Neutralization of the Heterologous ChAdOx1-S/BNT162b2 Vaccination: Secondary Analysis of the CombiVacS Study

Number of pages: 82 Posted: 25 Mar 2022
Carlos III Institute of Health - AIDS Immunopathogenesis Unit, Carlos III Institute of Health - CIBER de Epidemiología y Salud Pública (CIBERESP), Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clinic of Barcelona - Preventive Medicine and Epidemiology Service, Hospital Vall d’Hebron - Servicio de Medicina Preventiva y Epidemiología, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, Hospital Universitario Cruces, Hospital Clínic de Barcelona, Institut de Recerca Hospital Universitari Vall d’Hebron (VHIR) - Unidad de Soporte a la Investigación Clínica, Universidad Complutense de Madrid (UCM) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Carlos III Institute of Health, Carlos III Institute of Health, University of the Basque Country - Biocruces Bizkaia Health Research Institute, Hospital Clínic de Barcelona, Autonomous University of Barcelona - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria San Carlos (IdISSC) - Servicio de Farmacología Clínica, Instituto de Investigación Sanitaria Hospital "12 de Octubre" - Hospital Universitario 12 de Octubre, Carlos III Institute of Health - Laboratorio de Referencia en Inmunología, Carlos III Institute of Health, La Paz University Hospital - Servicio de Farmacología Clínica, Carlos III Institute of Health - National Centre for Microbiology and Independent
Downloads 49 (548,241)

Abstract:

Loading...

3.

Differential Effects of the Second SARS-CoV-2 mRNA Vaccine Dose on T Cell Immunity in Naïve and COVID-19 Recovered Individuals

Number of pages: 13 Posted: 12 May 2021
Icahn School of Medicine at Mount Sinai - Precision Immunology Institute, Hospital La Paz - Department of Immunology, Hospital La Paz - Department of Immunology, Hospital La Paz - Department of Immunology, Hospital La Paz - Department of Immunology, Hospital La Paz - Department of Immunology, University Hospital 12 de Octubre - Department of Immunology, Investigación Sanitaria Gregorio Marañón - Laboratory of Immune-Regulation, Investigación Sanitaria Gregorio Marañón - Laboratory of Immune-Regulation, IIS-Fundación Jiménez Díaz - Department of Nephrology, Hospital Universitario Marqués de Valdecilla-IDIVAL - Department of Immunology, Hospital Puerta de Hierro - Department of Pneumology, Hospital Puerta de Hierro - Department of Nephrology, Centro de Salud, Esquivias, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Carlos III Institute of Health - National Centre for Microbiology, Icahn School of Medicine at Mount Sinai - Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai - Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai - Department of Oncological Sciences, Duke-NUS Medical School - Programme in Emerging Infectious Diseases, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Icahn School of Medicine at Mount Sinai - Department of Pediatrics, Duke-NUS Medical School - Program in Emerging Infectious Diseases, Icahn School of Medicine at Mount Sinai - Department of Oncological Sciences and Icahn School of Medicine at Mount Sinai - Precision Immunology Institute
Downloads 35 (610,728)

Abstract:

Loading...